Paul Owen is the Chief Executive Officer for OneOme, a pharmacogenetic testing company co-founded with Mayo Clinic. Prior to OneOme, Paul led global commercialization for Invitae, a San Francisco-based hereditary disease diagnostics company listed on the New York Stock Exchange that went public during his tenure.
Prior to Invitae, Paul served as Vice Chair of Global Business Development for Mayo Clinic and was the leader of Mayo Medical Laboratories’ global commercial team – one of the world’s largest full-service reference labs. Paul has also held leadership roles at what is now Zimmer-Biomet and at Boston Scientific. Paul received his B.S. in business administration from the University of Wisconsin – Stout.